key: cord-0776702-od4rodx1
authors: Alessy, Saleh A.; Alhajji, Mohammed; Rawlinson, Janette; Baker, Matthew; Davies, Elizabeth A.
title: Factors influencing cancer patients’ experiences of care in the USA, United Kingdom, and Canada: A systematic review
date: 2022-04-21
journal: EClinicalMedicine
DOI: 10.1016/j.eclinm.2022.101405
sha: 97bfc54b277efeab0c6a1fca1e79ab396dd0f0c4
doc_id: 776702
cord_uid: od4rodx1

The extent to which individual and structural factors influence cancer patients’ reports of their experiences are not yet well understood. We sought to identify which groups of patients consistently report poorer experiences and whether structural care factors might also be associated with better or worse reports. We conducted a systematic review of literature in PubMed and Web of Science with the date of last search as 27th of February 2022 following PRISMA guidelines. We focused on studies from three established population-based surveys datasets and instruments. After screening 303 references, 54 studies met the inclusion criteria. Overall, being from an ethnic minority group, having a more deprived socioeconomic status, poorer general or mental health status, being diagnosed with poor prognosis cancers, presenting to care through an emergency route, and having delayed treatment were consistently associated with poorer cancer care experiences. Conversely being diagnosed with earlier stage disease, perceiving communication as effective, positive patient-provider relationships, and receiving treatment with respect were overall associated with better reports of cancer care experiences. Improvement efforts aimed at delivering better experiences of patient-centred care need to take account much more explicitly patients’ differing characteristics, prognoses, and trajectories they take through their care journeys.

Cancer patient experience is now developing both as a measure of cancer care quality to guide service improvements and as a research field in its own right. 1−3 Recently there has been an increase in research that attempts to explore variation in cancer patient experiences. Emerging research has documented variations in patients' experiences by either one or a combination of their demographic and disease progression factors. 4−10 The extent to which various factors influence cancer patients' experiences of care in different populations has not been assessed systematically due to the very recent development of this field.

Well-developed and large-scale surveys on patients' experiences with cancer care gather information that can be used to monitor and improve cancer care policies. Three cancer patient experience surveys have currently been validated and used at a national population level to assess patients' experiences with cancer care. Those are: The English Cancer Patient Experience Survey (CPES) in England, 11 The Consumer Assessment of Healthcare Providers and Systems (CAHPS) in USA, 12 and The Ambulatory Oncology Patient Satisfaction Survey (AOPSS) in Canada. 13, 14 We therefore systematically reviewed the available literature to identify all studies that have been published using the CAHPS, CPES, and AOPSS instruments or datasets in order to assess individual and structural factors found to influence cancer patients' experiences of care. The aim of our study was to synthesize the evidence to determine which factors appear to consistently affect cancer patients' experiences in different societies, with the goal of influencing cancer policy and efforts to improve cancer patients' experiences internationally.

We searched PubMed and Web of Science databases, with no year restrictions, to identify all studies (English language only) that used CPES, or CAHPS (focusing only on cancer care), or AOPSS instruments or datasets, with the date of last search as 27th of February 2022. Additionally, we used Google Scholar's advanced search feature "with the exact phrase" to identify published conference proceedings or any other possible study published in English using these surveys that might be indexed in other databases other than PubMed or Web of Science. Moreover, we also considered further articles for review that were mentioned in: the scoping review about cancer experience with care, 1 the popular systematic review on patients' experiences, 15 our previous systematic review 16 and the reference lists of identified studies. Mesh terms and keywords used for searching the database are listed in (Table 1) .

The goal of this study is to identify which factors have been associated with patients' reports of their cancer care experiences. We therefore included all journal articles that identified factors related to variation or differences in cancer patients' experiences. To expand the scope of this review, published conference proceedings in English with a sufficient description of study aims, included population, and statistical analyses were also considered. Several published conference proceedings were therefore also found duplicated as original journal articles with slightly different titles. Where the research findings were found to be duplicated, we kept only the articles published in journals. Studies of patient reported outcomes measures or quality of life were not included on the basis that they do not ask patients questions about their experiences, but rather about symptoms, activities, or care outcomes. In addition, we excluded studies that (1) focused on patient satisfaction, (2) did not assess patient experiences (3) compared hospital performance (4) assessed the accuracy of patient experience data rather than reported patients' experiences or (5) were reliability studies.

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). 17 SA searched databases, initially screened articles, and chose the potential articles for a full text read. These potentially relevant studies were obtained as full text and assessed independently for inclusion by SA and ED, who then discussed and agreed on their inclusion. Finally, all study details were extracted from the full text publication by SA and then independently reviewed by MA and ED. Out of the 303 studies retrieved from our search, 54 studies met the inclusion criteria ( Figure 1 ).

All quantitative full journal articles (n = 41) were then critically appraised and assigned a quality score using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies designed by the National Institute of Health (NIH) 18 (supplementary data). This step was carried out by an independent reviewer (MA) who was not involved in article selection to minimize the bias in assessing articles. The reason we chose this quality assessment tool was because most of the studies included in this review were cross sectional. Conference proceedings (n = 7) were not quality assessed as they were not full studies, and qualitative and mixed methods studies (n = 6) were not assessed due to heterogeneity in their designs. Most studies in this review followed the established process for the three major surveys with results and response rates being publicly reported. Studies were evaluated based on what was explicitly reported in the paper and we did not attempt to determine this by context. We did not exclude any articles based on their quality score, rather we aimed to assess the quality of the design and evidence in each study.

Evidence before this study Patient experience is evolving as an indicator of cancer care quality, and evidence suggests that care experiences vary significantly. Our previous review, in which we used mesh terms "patient experience" and "cancer" and "survival" to identify all articles published from January 1998 until March 2018 in the Medline database, returned 16 eligible articles, and showed variations in cancer patients' survival by their reported experiences of care. However, no systematic review has yet synthesized and documented factors influencing cancer patients' experiences.

Our systematic review showed that patients' experiences across several countries are consistently influenced by their demographic characteristics, aspects of their prognosis and system organisation issues. The factor most associated with negative patient care experiences is being from an ethnic minority background.

Inequality exists in reported patients' care experiences at an international level. Rather than designing improvement initiatives that take a "one size fits all" approach to care experiences, policy makers should consider patients' characteristics, their prognoses, and the differing trajectories they take through their care journeys.

No ethical approval was required for this study.

The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. SA and ED had access to the bibliographic search database. All authors had access to the included study data and all authors agreed with the final decision to submit for publication.

Most of the final included studies were from the United Kingdom due the availability of cancer patient experience datasets since 2010, with several recently published studies from Canada, USA, and Australia (Table 2) . Authors' names, the study aim, design, and a summary of findings were extracted for each study into Table 3 . Most of the included studies were similar in design being quantitative cross-sectional studies including large numbers of patients diagnosed over one or several years (n = 48), but there was also one mixed method and five qualitative studies. Several factors were found to affect cancer patients' experiences consistently across diverse cancer populations. These included patient demographic characteristics (age, sex, ethnicity, area of residence, socioeconomic status), health status, cancer type, cancer prognosis, patients' presentation to cancer care, treatment facility location, and patients' interactions with health providers. In addition, other structural factors such as health plan, hospital size, and survey responders' characteristics were also found to influence patients' experiences, but the extent of this varied between different populations. We summarized all factors influencing patients' experiences into three main categories: (1) patients' cancer types and demographic characteristics;

(2) patients' interactions with the healthcare system; and (3) survey administration. When studies crossed more than one category, we categorised them based on the main aim as stated in the study objective. Positive and negative influences on experiences, when these occurred in at least two or more studies are summarised as an evidence synthesis in Figure 2 and Table 4 .

A total of 30 studies linked variation in patients' experiences to their demographic or disease characteristics. A full list of these studies' citations and summaries can be found in Table 3 . Published studies from several yearly rounds of CPES documented variation in patients' experiences with primary care, involvement in treatment decisions, health provider communication, and overall care experience by their sex, age, and ethnicity. 4,19−28 These studies showed that overall, younger patients reported less positive experiences than older ones, 20, 22, 24 females reported less positive experiences than males, 20 and non-white patients reported less positive experiences than those from the white population. 4, 20, 22, 29 Similar variation in cancer patients' experiences by their sex, age, and ethnicity were also found in studies from USA, 30−32 and Canada. 33 Furthermore, residence area and socioeconomic status were found to influence patients' experiences. For example, patients from the urban capital city of London tend to report less positive experiences than those from other areas of England. 7 In addition, cancer patients in rural areas in the United States report better experiences with timely care than those in urban areas, 8, 34 and patients who are enrolled in both Medicare and Medicaid (and who therefore tend to be more deprived) report better care experiences with prescription drug plans and health plans than patients enrolled in Medicare-only. 9 Moreover, Halpern and colleagues assessed care experiences among patients with cancer in the year before death, and found better mental health and being a longer time before death were associated with better experiences. 31 Another study using the same dataset found that better reported health status and better mental health were associated with reporting a better care experience, while worse mental health was associated with worse care experiences. 35, 36 Patients' comorbidities were also shown to influence their experiences, with patients who had higher illness burden reporting worse care experiences, but the direction of this association varied between different cancer types. 37, 38 Variations in patients' experiences of cancer care were not limited to patient sociodemographic characteristics but were also documented by cancer site and disease prognosis. For example, patients with prostate cancer tend to report the worst experiences of being referred for emotional support in Canada. 39 In terms of experience with cancer diagnosis, patients who were diagnosed with late stage disease were more likely to report worse care experiences in England, 40 and in the USA. 41−43 Moreover, patients with multiple myeloma and pancreatic cancer were more likely to report negative experiences in England, 19 To assess if CPES sampling processes, post-sampling mortality and nonresponse can influence the CPES representativeness.

3

The overall response rate to CPES was 67%, being thyroid, vulvar, and multiple myeloma cancers were more likely to report negative experiences in Australia. 45 In addition, patients with cancer of unknown primary in England were more likely to prefer more written information about their type of cancer and tests received compared to those with metastatic disease of known primary. 46 Generally, it seems therefore that patients presenting with uncommon cancers or more advanced disease, which means they are facing an uncertain prognosis, tend to report less positive care experiences.

Five studies assessed how CPES sampling and the survey administration processes influenced reported patients' experiences. 47−50 Abel and colleagues found that patients with brain and pancreatic cancers had the highest risk of post-sampling mortality meaning that individuals who had initially been included in CPES sampling, died before the survey mail out could be carried out and so were excluded. 47 These findings about the limitations of CPES representativeness were also confirmed by two other studies that compared the survey responders to the general cancer population of the same cancer in England. 48, 49 These studies found patients who are included in CPES tend to be less deprived, more likely to be from a white background, and to have better prognoses. 48, 49 Survey methodology and the timing of response were also shown to influence patients' reported experiences. Patients who responded online reported better overall experience of care than those who responded through mail. 50 Also, patients who completed the survey between 8 and 12 months after their diagnosis reported a higher global rating of care compared to those who completed it between 0 and 3 months after. 38 In addition, a qualitative study comparing the CPES 2019 results with those obtained using the same questions at focus groups and interviews suggested whether the survey questions were not specific enough to represent patients' experiences in sufficient detail. 51 Interactions with the healthcare system Nineteen studies linked variation in patients' experiences to their interactions with the healthcare system or their care providers. 5,6,59,60,40,52−58 First, patients' presentation pathways to cancer care were associated with their reported care experiences. 5, 40, 54, 56 For example, studies using CPES datasets showed that patients who presented to cancer care through emergency care or those who had multiple consultations with primary care prior to referral tended to report negative care experiences with cancer care. 5, 40, 54, 56 This association was also shown in the USA where patients who had used an emergency department after their cancer diagnosis cancer reported worse care experiences. 61 In contrast, patients reported better experiences when they were diagnosed at an earlier disease stage or presented to care through the screening-detection route of diagnosis. 5, 40 In the USA, no difference in care experiences was found for patients who received care through a shared care pathway compared to those receiving either oncologist led care or primary care provider-led care. 62 However, another study from USA using the same dataset found that elderly patients with advanced stage colon cancer who received the Guideline Concordant Cancer Care pathway reported better care experiences with getting needed care. 63 Care coordination and communication with healthcare providers were found to influence patients' experiences. Specifically, studies from the UK, Canada, and the USA showed that patients reporting effective communication, better patient-provider relationship, being treated as a person with respect and dignity, care that takes patients' needs into considerations, and better care administration and coordination 6, 53, 57, 60 as key aspects in improving their overall care experiences. 6, 53, 57, 60 In the UK, two studies of the role of clinical nurse specialists in cancer care found that contact with them was subsequently associated better experiences of involvement in treatment decisions, care co-ordination and being treated with more respect and dignity. 64 Some studies reported more than one factor; hence we categorized such study based on the first aim.

improve adherence to office visits for colorectal cancer surveillance in USA. 57 In addition patients who reported that their self-goal of treatment was to cure their cancer rather than to control it reported better experiences with access to care, coordination of care, respect for patient preferences, communication, and emotional support. 66 Patients' experiences with care were also associated with hospital size and treatment received. For instance, patients reported better experiences in hospitals where there were more cancer specialist nurses. 52 Additionally, patients who received radiation therapy were more likely to report their overall care as better than those not receiving this treatment. 58 while those who had shorter hospital stays (less than 6 days) were more likely to report better experiences than those stayed longer. 59 Delays in receiving cancer treatment were also associated with reporting worse care experiences. Patients in USA who were treated more than 6 months after their cancer diagnosis reported worse overall care, health plan, and getting needed care measures than patients treated less than two months from diagnosis. Finally, hospitals with higher CPES response rates also report better experiences. Since non-responders and late responders are less positive about their care, a low survey response is seen as an indicator of poorer experiences for a given hospital. 55

Patient centred cancer care should be tailored to patients' needs and preferences. 68 This review finds that the patient experience research field is emerging in many countries 69 and large amounts of data are now being collected and reported on patients' experiences in many differing healthcare systems. Our study has revealed that a wide range of factors can influence cancer patients' reported experiences including their demographic characteristics, health status, cancer type and prognosis, and interactions with particular aspects of the healthcare system, as well as the survey experience collection methods. Patients' demographic and cancer characteristics were the factors associated in the most pronounced way with variation in patients' experiences across all studies. Being from an ethnic minority group, having a more deprived socioeconomic status, or poorer general or mental health status, were factors consistently associated with poorer cancer care experiences. In addition, being diagnosed with advanced stage disease, less common cancer types that carried a poorer prognosis, presenting to care through an emergency route, and having delayed treatment were also associated with less positive experiences. Conversely being diagnosed with earlier stage disease, perceiving communication as effective, positive patient-provider relationships, and receiving treatment with respect and dignity were associated overall with better overall reports of cancer care experiences.

Several systematic reviews have previously focused on cancer patients' experiences. 1, 16, 70 Saunders and colleagues, for example, highlighted variation in the emerging patients' experiences measures worldwide. 70 These variations in care experiences by factors such as sex, higher comorbidity, and ethnic background are observed not only in the cancer patient experience literature, but are known to occur in patient experience results for many different health conditions. 71 Our study summarised evidence gathered from specifically designed surveys on what factors impact patients' experiences in three developed healthcare systems. In addition, Mollica and colleagues conducted a scoping review explaining the landscape of cancer patients' experiences research in USA when introducing the SEER-CAHPS linked dataset. Our study examined subsequent evidence generated from recently published studies from SEER-CAHPS linked dataset, revealing variation in cancer patients' experiences in USA. Although the structure of cancer care in USA is different from the UK and Canada, there were several consistent individual factors affecting patients' experiences across these systems such as patients' ethnicity and their cancer type.

To our knowledge, this is the first systematic review to focus on assessing factors influencing the experiences of cancer patients. In addition, this is the first such review to focus on studies that specifically aim to measure patients' experiences and have been published from large patient experience datasets recently available in USA, 12 England, 72 and Canada. 13 Based on our review design and inclusion criteria, the heterogeneity between studies was limited, and most showed a high degree of similarity in their purposes, design, sample size, and concepts. While this review is comprehensive in terms of searching several databases, studies that used other tools to assess patients' experiences were excluded together with data from healthcare systems in other areas of the world. The review also did not include studies that focused on the relationship between cancer experiences and other cancer outcomes as other work has previously examined this. 16 Some studies had more than one aim and while we assigned and categorised the first aim for this review, inevitably this led to some loss of information which future researchers might wish to avoid.

In addition, findings from this study may not necessarily represent all the included countries similarly. Although the included papers were from different countries, most of them were from the UK, followed by USA. This was mainly due to the nature of the existing literature in the field of cancer patient experience in these countries. Although the included studies have reported cancer care experiences for different ethnic groups, these studies were all from high income countries limiting the generalisability of this study to low resource and developing settings. In addition, previous research has also documented limitations in capturing the experiences of all cancer patient groups in patient experiences surveys, especially for ethnic minorities and lower survival groups. 47−49 Findings from this study are important for policy makers, practitioners, and patient experience researchers as they emphasise that the experiences of patients with cancer are influenced by several different factors or a combination of them. Efforts to improve patients' experiences or survivorship programs among individuals with cancer should carefully consider what might affect patients' experiences to be able to prioritise or propose improvement initiatives. In addition, this study also shows that cancer care programs should not be designed as "one size fits all". For example, several studies included in this review showed that there is a variation in patients' experiences by cancer site with which patients present, even after adjustments for socio-demographic factors in both CPES and CAHPS. This raises the importance of more tailored experience improvement initiatives by oncology services and the need for programmes that take account of a range of patients' characteristics, their different cancers, and the different trajectories they take through their care journeys. For example, patients in England who present to cancer care through emergency presentation tended to report poorer care experiences compared to patients presenting to care with screen-detected good prognosis cancer. 40 This suggests that the speed and success of a relatively straightforward diagnostic phase can have farreaching positive effects in terms of confidence that patients may feel in the cancer care system and its ability to care for them. Consequently, when a diagnosis has been difficult or delayed, more time and effort may be needed 'to repair' the effects of what appears an uncoordinated beginning to cancer care. In addition, the consistent difference in experiences reported by patients from non-white ethnic groups across three differing health systems suggests that more work is needed to understand what lies behind these experiences, how these may be improved and how to co-design solutions.

There is also emerging evidence that clinical nurse specialists play an important role in that their care is associated with better experiences of involvement in treatment decisions, care co-ordination and being treated with more respect and dignity. 64 Further research on their role and other ways of co-ordinating care around individuals is needed. Specifically, our findings can also inform researchers and survey designers about the similarity and heterogeneity of patients' experiences to inform new analyses about how to improve rather than to continue to simply document these differences. Our study has also documented the variety of instruments used to measure and analyse cancer patients' experiences of care from one care setting to another, creating a synthesis of knowledge on how to approach cancer patients' experiences reliably and effectively. 2, 73, 74 These findings will also be of use to clinician and nursing leaders, managers, and policy makers charged with the responsibility of deciding just where to focus quality improvements efforts for individual hospitals, cancer centres, regional or indeed national populations. Understanding where the largest inequalities in experiences lie and the structural aspects of care that may underlie them makes it easier to decide where to concentrate efforts and maintain momentum. Finally, the coronavirus disease (COVID-19) pandemic has affected the capacity of cancer care in many countries causing services disruptions and leading to the implementation of telemedicine in cancer care. 75 Patients' experiences with the remote consultation and support will be even more vital to understand, given the digital divides worldwide. 76 Further research both on the effect of the pandemic on care experiences and on effective ways to improve and sustain experiences using survey data and other qualitative data are urgently needed.

Patient experience is developing both as a quality indicator and as a research topic in many care settings including cancer care. This systematic review focussed on studies that were published from or used the instruments of CAHPS, CPES, and AOPSS and assessed factors influencing cancer patients' experiences of care. We showed that cancer type, prognosis, and demographic characteristics have now been consistently linked with variation in patients' experiences. Understanding how experiences vary between different populations and what actually lies beneath these differences, can help practitioners and policy makers prioritise initiatives to improve patients' experiences within their cancer care systems. These findings show that improvement efforts in cancer care experience are not yet meeting the needs of all groups in society and that ideal cancer care pathways cannot therefore be designed as "one size fits all" approach. Our findings underline the importance of actively designing patient or person-centred systems around patients' particular characteristics, their differing cancers, and the different trajectories they take through their care journeys.

SA, and ED designed the study, and decided the analytic approach, and agreed on eligible articles. MA assessed the quality of the articles. All authors (SA, MA, JR, MB, and ED) contributed to the interpretation of the results and the writing of this manuscript.

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. This work is part of Saleh Alessy's PhD project, which is fully sponsored by Ministry of Education, Riyadh, Saudi Arabia.

Data extraction tables and figures are available from SA.

None.

Patient experiences of cancer care: scoping review, future directions, and introduction of a new data resource: surveillance epidemiology and end resultsconsumer assessment of healthcare providers and systems (SEER-CAHPS)

Development and testing of the CAHPS cancer care survey

The cancer patient experiences questionnaire (CPEQ): reliability and construct validity following a national survey to assess hospital cancer care from the patient perspective

Minority ethnicity patient satisfaction and experience: results of the national cancer patient experience survey in England

Diagnostic route is associated with care satisfaction independently of tumour stage: evidence from linked English cancer patient experience survey and cancer registration data

Patient experience drivers of overall satisfaction with care in cancer patients: evidence from responders to the English Cancer patient experience survey

What explains worse patient experience in London? Evidence from secondary analysis of the cancer patient experience survey

Examining urban and rural differences in perceived timeliness of care among cancer patients: a SEER-CAHPS study

Care experiences among dually enrolled older adults with cancer: SEER-CAHPS

Exploring experiences of cancer care in Wales: a thematic analysis of free-text responses to the

Wales Cancer Patient Experience Survey (WCPES)

National Cancer Patient Experience Survey

Unveiling SEER-CAHPS Ò : a new data resource for quality of care research

Understanding the experiences of cancer patients as they transition from treatment to primary and community care: a Pan-Canadian study of over 13,000 cancer survivors

The patient experience of ambulatory cancer treatment: a descriptive study

A systematic review of evidence on the links between patient experience and clinical safety and effectiveness

How have patients' experiences of cancer care been linked to survival? A systematic review

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. National Institutes of Health

Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 national cancer patient experience survey in England

Inequalities in the care experiences of patients with cancer: analysis of data from the national cancer patient experience survey

Variation in reported experience of involvement in cancer treatment decision making: evidence from the national cancer patient experience survey

Inequalities in reported cancer patient experience by socio-demographic characteristic and cancer site: evidence from respondents to the English cancer patient experience survey

Keeping the customer satisfied #2 It Is OK To Ask -who are we asking, and who participates? Further findings from the national cancer patient experience survey

Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study

Ethnic variation in patients' ratings of communication: analysis of national cancer patient experience survey data

Qualitative analysis of 6961 free-text comments from the first national cancer patient experience survey in Scotland

The cancer care experiences of gay, lesbian and bisexual patients: a secondary analysis of data from the UK Cancer Patient Experience Survey

Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English cancer patient experience survey linked with the national cancer registry. Support Care Cancer

Ethnic variation in cancer patients' ratings of information provision, communication and overall care

Patient experience and quality of urologic cancer surgery in US hospitals

The health care experience of patients with cancer during the last year of life: analysis of the SEER-CAHPS data set

Racial differences in lung cancer patient experiences with medical care and their association with cancer mortality: a SEER-CAHPS study

Cancer information-seeking preferences linked to distinct patient experiences and differential satisfaction with cancer care

Perceptions of care coordination among older adult cancer survivors: a SEER-CAHPS study

Healthcare experience among older cancer survivors: analysis of the SEER-CAHPS dataset

Associations between perceptions of care experiences and receipt of mental health care among older adults with cancer

Illness burden is associated with care experience measures among Medicare beneficiaries surveyed before or after a cancer diagnosis

Understanding quality and equity : patient experiences with care in older adults diagnosed with hematologic malignancies. Cancer Causes Control

The experience of patients with cancer during diagnosis and treatment planning: a descriptive study of Canadian survey results

Associations between diagnostic pathways and care experience in colorectal cancer: evidence from patient-reported data

Racial /ethnic disparities in patient experiences with health care in association with earlier stage at colorectal cancer diagnosis findings from the SEER-CAHPS data

Racial /ethnic differences in patient experiences with health care in association with earlier stage at breast cancer diagnosis : findings from the SEER -CAHPS data

Racial/ethnic disparities in patient experiences with care and Gleason score at diagnosis of prostate cancer: a SEER-CAHPS study. Cancer Causes Control

How do myeloma patients' experiences before and during diagnosis compare to those for all cancers? Findings from secondary analysis of the National Cancer Patient Experience Survey

Presentations to general practice before a cancer diagnosis in Victoria: a cross-sectional survey

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England

Post-sampling mortality and non-response patterns in the English cancer patient experience survey: implications for epidemiological studies based on surveys of cancer patients

How representative are colorectal, lung, breast and prostate cancer patients responding to the national cancer patient experience survey (CPES) of the cancer registry population in England? A population-based case control study

Is the English cancer patient experience survey representative? A comparative analysis with the national lung cancer audit

Predictors of postal or online response mode and associations with patient experience and satisfaction in the English cancer patient experience survey

Analysis of local qualitative cancer patient experience alongside the 2019 results of the UK national cancer patient experience survey

Is a larger specialist nurse workforce in cancer care associated with better patient experience? Cross-sectional study

Cancer patients' respect experiences in relation to perceived communication behaviours from hospital staff: analysis of the 2012−2013 national cancer patient experience survey

Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English cancer patient experience survey

Do differential response rates to patient surveys between organizations lead to unfair performance comparisons?

Emergency diagnosis of cancer and previous general practice consultations: insights from linked patient survey data

Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study

Patient experiences of care in localized prostate cancer

Patient satisfaction after lung cancer surgery: do clinical outcomes affect hospital consumer assessment of health care providers and systems scores?

Exploring the perspectives of patients about their care experience: identifying what patients perceive are important qualities in cancer care. Support Care Cancer

Health care experiences for older adults diagnosed with leukemia and lymphoma: factors associated with emergency department use, timeliness and access of health care

Associations between shared care and patient experiences among older cancer survivors

Association of patient experience with guideline-concordant colon cancer treatment in the elderly

Being assigned a clinical nurse specialist is associated with better experiences of cancer care: English population-based study using the linked national cancer patient experience survey and cancer registration dataset

Exploring patient experiences of cancer care in Northern Ireland: a thematic analysis of free-text responses to the 2018 Northern Ireland patient experience survey (NICPES)

A cross-sectional analysis of ambulatory oncology experience by treatment intent

Time-to-treatment after cancer diagnosis and the patient experience with care: a SEER-CAHPS study

Delivering High-Quality Cancer Care. Washington, D.C.: National Academies Press

The consumer has spoken: patient experience is now healthcare's core differentiator

Cancer patient experience measures: an evidence review

Adult inpatient Survey 2020. Care Quality Commission

Comparison of the linked cancer registry and cancer patient experience survey datasets in england and the United States

Reliability of hospital scores for the Cancer Patient Experience Survey: analysis of publicly reported patient survey data

The underlying structure of the English Cancer Patient Experience Survey: factor analysis to support survey reporting and design

Telemedicine for Cancer Care in the Time of COVID-19

Can you do what I'm asking you to do?

We thank Dr Ali Alqarni from King's College London for help visualising the data.